{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T23:23:43Z","timestamp":1771629823604,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82370173"],"award-info":[{"award-number":["No. 82370173"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00011-025-02014-7","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T05:37:53Z","timestamp":1745905073000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immune-related genetic single-nucleotide polymorphisms contribute to prognosis and response to chemotherapy in patients with acute lymphoblastic leukemia"],"prefix":"10.1007","volume":"74","author":[{"given":"Amin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wancheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Can","family":"Can","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hexiao","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanyang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daoxin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"2014_CR1","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/S0140-6736(19)33018-1","volume":"395","author":"F Malard","year":"2020","unstructured":"Malard F, Mohty M. Acute lymphoblastic leukaemia, lancet Lond. Engl. 2020;395:1146\u201362. https:\/\/doi.org\/10.1016\/S0140-6736(19)33018-1.","journal-title":"Engl"},{"key":"2014_CR2","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1038\/s41591-021-01497-1","volume":"27","author":"S Cordoba","year":"2021","unstructured":"Cordoba S, Onuoha S, Thomas S, Pignataro DS, Hough R, Ghorashian S, Vora A, Bonney D, Veys P, Rao K, Lucchini G, Chiesa R, Chu J, Clark L, Fung MM, Smith K, Peticone C, Al-Hajj M, Baldan V, Ferrari M, Srivastava S, Jha R, Arce Vargas F, Duffy K, Day W, Virgo P, Wheeler L, Hancock J, Farzaneh F, Domning S, Zhang Y, Khokhar NZ, Peddareddigari VGR, Wynn R, Pule M, Amrolia PJ. CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial. Nat Med. 2021;27:1797\u2013805. https:\/\/doi.org\/10.1038\/s41591-021-01497-1.","journal-title":"Nat Med"},{"key":"2014_CR3","doi-asserted-by":"publisher","first-page":"5564","DOI":"10.26355\/eurrev_202005_21342","volume":"24","author":"S-S Chen","year":"2020","unstructured":"Chen S-S, Wu W-Z, Zhang Y-P, Huang W-J. Gene polymorphisms of SOCS1 and SOCS2 and acute lymphoblastic leukemia. Eur Rev Med Pharmacol Sci. 2020;24:5564\u201372. https:\/\/doi.org\/10.26355\/eurrev_202005_21342.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2014_CR4","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.ccell.2020.04.015","volume":"37","author":"MT Witkowski","year":"2020","unstructured":"Witkowski MT, Dolgalev I, Evensen NA, Ma C, Chambers T, Roberts KG, Sreeram S, Dai Y, Tikhonova AN, Lasry A, Qu C, Pei D, Cheng C, Robbins GA, Pierro J, Selvaraj S, Mezzano V, Daves M, Lupo PJ, Scheurer ME, Loomis CA, Mullighan CG, Chen W, Rabin KR, Tsirigos A, Carroll WL, Aifantis I. Extensive remodeling of the immune microenvironment in B cell acute lymphoblastic leukemia. Cancer Cell. 2020;37:867\u2013e88212. https:\/\/doi.org\/10.1016\/j.ccell.2020.04.015.","journal-title":"Cancer Cell"},{"key":"2014_CR5","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1038\/ncomms4273","volume":"5","author":"BC Belyea","year":"2014","unstructured":"Belyea BC, Xu F, Pentz ES, Medrano S, Li M, Hu Y, Turner S, Legallo R, Jones CA, Tario JD, Liang P, Gross KW, Sequeira-Lopez MLS, Gomez RA. Identification of Renin progenitors in the mouse bone marrow that give rise to B-cell leukaemia. Nat Commun. 2014;5:3273. https:\/\/doi.org\/10.1038\/ncomms4273.","journal-title":"Nat Commun"},{"key":"2014_CR6","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1182\/blood.2021014495","volume":"140","author":"Y Li","year":"2022","unstructured":"Li Y, Yang X, Sun Y, Li Z, Yang W, Ju B, Easton J, Pei D, Cheng C, Lee S, Pui C-H, Yu J, Chi H, Yang JJ. Impact of T-cell immunity on chemotherapy response in childhood acute lymphoblastic leukemia. Blood. 2022;140:1507\u201321. https:\/\/doi.org\/10.1182\/blood.2021014495.","journal-title":"Blood"},{"key":"2014_CR7","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1182\/blood-2013-05-500850","volume":"122","author":"A Perez-Garcia","year":"2013","unstructured":"Perez-Garcia A, Ambesi-Impiombato A, Hadler M, Rigo I, LeDuc CA, Kelly K, Jalas C, Paietta E, Racevskis J, Rowe JM, Tallman MS, Paganin M, Basso G, Tong W, Chung WK, Ferrando AA. Genetic loss of SH2B3 in acute lymphoblastic leukemia. Blood. 2013;122:2425\u201332. https:\/\/doi.org\/10.1182\/blood-2013-05-500850.","journal-title":"Blood"},{"key":"2014_CR8","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1182\/blood.2022016243","volume":"140","author":"L Zhao","year":"2022","unstructured":"Zhao L, Li S, Wei X, Qi X, Liu D, Liu L, Wen F, Zhang J-S, Wang F, Liu Z-L, Cao YJ. A novel CD19\/CD22\/CD3 trispecific antibody enhances therapeutic efficacy and overcomes immune escape against B-ALL. Blood. 2022;140:1790\u2013802. https:\/\/doi.org\/10.1182\/blood.2022016243.","journal-title":"Blood"},{"key":"2014_CR9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1530\/ERC-17-0033","volume":"24","author":"TS Plantinga","year":"2017","unstructured":"Plantinga TS, Petrulea MS, Oosting M, Joosten LAB, Piciu D, Smit JW, Netea-Maier RT, Georgescu CE. Association of NF-\u03baB polymorphisms with clinical outcome of non-medullary thyroid carcinoma. Endocr Relat Cancer. 2017;24:307\u201318. https:\/\/doi.org\/10.1530\/ERC-17-0033.","journal-title":"Endocr Relat Cancer"},{"key":"2014_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/nri2476","volume":"9","author":"I-C Ho","year":"2009","unstructured":"Ho I-C, Tai T-S, Pai S-Y. GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation. Nat Rev Immunol. 2009;9:125\u201335. https:\/\/doi.org\/10.1038\/nri2476.","journal-title":"Nat Rev Immunol"},{"key":"2014_CR11","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41588-021-00993-x","volume":"54","author":"H Yang","year":"2022","unstructured":"Yang H, Zhang H, Luan Y, Liu T, Yang W, Roberts KG, Qian M-X, Zhang B, Yang W, Perez-Andreu V, Xu J, Iyyanki S, Kuang D, Stasiak LA, Reshmi SC, Gastier-Foster J, Smith C, Pui C-H, Evans WE, Hunger SP, Platanias LC, Relling MV, Mullighan CG, Loh ML, Yue F, Yang JJ. Noncoding genetic variation in GATA3 increases acute lymphoblastic leukemia risk through local and global changes in chromatin conformation. Nat Genet. 2022;54:170\u20139. https:\/\/doi.org\/10.1038\/s41588-021-00993-x.","journal-title":"Nat Genet"},{"key":"2014_CR12","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/j.1365-2141.2011.08632.x","volume":"153","author":"K Butterbach","year":"2011","unstructured":"Butterbach K, Beckmann L, de Sanjos\u00e9 S, Benavente Y, Becker N, Foretova L, Maynadie M, Cocco P, Staines A, Boffetta P, Brennan P, Nieters A. Association of JAK-STAT pathway related genes with lymphoma risk: results of a European case-control study (EpiLymph). Br J Haematol. 2011;153:318\u201333. https:\/\/doi.org\/10.1111\/j.1365-2141.2011.08632.x.","journal-title":"Br J Haematol"},{"key":"2014_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6131","author":"C Gu","year":"2023","unstructured":"Gu C, Can C, Liu J, Wei Y, Yang X, Guo X, Wang R, Jia W, Liu W, Ma D. The genetic polymorphisms of immune-related genes contribute to the susceptibility and survival of lymphoma. Cancer Med. 2023. https:\/\/doi.org\/10.1002\/cam4.6131.","journal-title":"Cancer Med"},{"key":"2014_CR14","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/ejh.13034","volume":"100","author":"M Lindgren","year":"2018","unstructured":"Lindgren M, Samuelsson J, Nilsson L, Knutsen H, Ghanima W, Westin J, Johansson PL, Andr\u00e9asson B. Genetic variation in IL28B (IFNL3) and response to interferon-alpha treatment in myeloproliferative neoplasms. Eur J Haematol. 2018;100:419\u201325. https:\/\/doi.org\/10.1111\/ejh.13034.","journal-title":"Eur J Haematol"},{"key":"2014_CR15","doi-asserted-by":"publisher","first-page":"156401","DOI":"10.1016\/j.cyto.2023.156401","volume":"172","author":"I Serin","year":"2023","unstructured":"Serin I, Colak Y, Oyaci Y, Tuncel FC, Pehlivan M, Pehlivan S. Effect of interleukin-2 (IL-2) polymorphisms on multiple myeloma: IL-2RA rs2104286, IL-2 rs2069762 and rs2069763 polymorphisms. Cytokine. 2023;172:156401. https:\/\/doi.org\/10.1016\/j.cyto.2023.156401.","journal-title":"Cytokine"},{"key":"2014_CR16","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1002\/cncr.20668","volume":"101","author":"H Kantarjian","year":"2004","unstructured":"Kantarjian H, Thomas D, O\u2019Brien S, Cortes J, Giles F, Jeha S, Bueso-Ramos CE, Pierce S, Shan J, Koller C, Beran M, Keating M, Freireich EJ. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia. Cancer. 2004;101:2788\u2013801. https:\/\/doi.org\/10.1002\/cncr.20668.","journal-title":"Cancer"},{"key":"2014_CR17","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1038\/s41409-021-01422-7","volume":"56","author":"Y Akahoshi","year":"2021","unstructured":"Akahoshi Y, Arai Y, Nishiwaki S, Tachibana T, Shinohara A, Doki N, Uchida N, Tanaka M, Kanda Y, Shiratori S, Ozawa Y, Shono K, Katayama Y, Tanaka J, Fukuda T, Atsuta Y, Kako S. Newly proposed threshold and validation of white blood cell count at diagnosis for Philadelphia chromosome-positive acute lymphoblastic leukemia: risk assessment of relapse in patients with negative minimal residual disease at transplantation-a report from the adult acute lymphoblastic leukemia working group of the JSTCT. Bone Marrow Transpl. 2021;56:2842\u20138. https:\/\/doi.org\/10.1038\/s41409-021-01422-7.","journal-title":"Bone Marrow Transpl"},{"key":"2014_CR18","doi-asserted-by":"publisher","first-page":"e2225647","DOI":"10.1001\/jamanetworkopen.2022.25647","volume":"5","author":"C Chen","year":"2022","unstructured":"Chen C, Song N, Dong Q, Sun X, Mulder HL, Easton J, Zhang J, Yasui Y, Bhatia S, Armstrong GT, Wang H, Ness KK, Hudson MM, Robison LL, Wang Z. Association of Single-Nucleotide variants in the human leukocyte antigen and other loci with childhood hodgkin lymphoma, JAMA Netw. Open. 2022;5:e2225647. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.25647.","journal-title":"Open"},{"key":"2014_CR19","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1038\/ng.2803","volume":"45","author":"V Perez-Andreu","year":"2013","unstructured":"Perez-Andreu V, Roberts KG, Harvey RC, Yang W, Cheng C, Pei D, Xu H, Gastier-Foster J, Lim SEJY-S, Chen I-M, Fan Y, Devidas M, Borowitz MJ, Smith C, Neale G, Burchard EG, Torgerson DG, Klussmann FA, Villagran CRN, Winick NJ, Camitta BM, Raetz E, Wood B, Yue F, Carroll WL, Larsen E, Bowman WP, Loh ML, Dean M, Bhojwani D, Pui C-H, Evans WE, Relling MV, Hunger SP, Willman CL, Mullighan CG, Yang JJ. Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse. Nat Genet. 2013;45:1494\u20138. https:\/\/doi.org\/10.1038\/ng.2803.","journal-title":"Nat Genet"},{"key":"2014_CR20","doi-asserted-by":"publisher","first-page":"e2120787119","DOI":"10.1073\/pnas.2120787119","volume":"119","author":"Y-T Dai","year":"2022","unstructured":"Dai Y-T, Zhang F, Fang H, Li J-F, Lu G, Jiang L, Chen B, Mao D-D, Liu Y-F, Wang J, Peng L-J, Feng C, Chen H-F, Mu J-X, Zhang Q-L, Wang H, Ariffin H, Moy T.A., Wang J.-H., Lou Y.-J., Chen S.-N., Wang Q., Liu H., Shan Z., Matsumura I, Miyazaki Y., Yasuda T., Dou L.-P., Yan X.-J., Yan J.-S., Yeoh A.E.-J., Wu D.-P., Kiyoi H., Hayakawa F., Jin J., Wang S.-Y., Sun X.-J., Mi J.-Q., Chen Z., Huang J.-Y., Chen S.-J. Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases. Proc Natl Acad Sci U S A. 2022;119:e2120787119. https:\/\/doi.org\/10.1073\/pnas.2120787119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2014_CR21","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12943-019-1106-z","volume":"18","author":"T Lan","year":"2019","unstructured":"Lan T, Li H, Zhang D, Xu L, Liu H, Hao X, Yan X, Liao H, Chen X, Xie K, Li J, Liao M, Huang J, Yuan K, Zeng Y, Wu H. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3, mol. Cancer. 2019;18:186. https:\/\/doi.org\/10.1186\/s12943-019-1106-z.","journal-title":"Cancer"},{"key":"2014_CR22","unstructured":"LncRNA GATA3-AS. 1 facilitates tumour progression and immune escape in triple-negative breast cancer through destabilization of GATA3 but stabilization of PD-L1 - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/32687248\/ (accessed July 28, 2023)."},{"key":"2014_CR23","doi-asserted-by":"publisher","first-page":"7028","DOI":"10.1158\/1078-0432.CCR-07-5017","volume":"14","author":"RA Egler","year":"2008","unstructured":"Egler RA, Burlingame SM, Nuchtern JG, Russell HV. Interleukin-6 and soluble interleukin-6 receptor levels as markers of disease extent and prognosis in neuroblastoma, clin. Cancer Res Off J Am Assoc Cancer Res. 2008;14:7028\u201334. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-5017.","journal-title":"Cancer Res Off J Am Assoc Cancer Res"},{"key":"2014_CR24","unstructured":"An intermediate-risk. multiple myeloma subgroup is defined by sIL-6r: levels synergistically increase with incidence of SNP rs2228145 and 1q21 amplification - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/22072558\/ (accessed July 28, 2023)."},{"key":"2014_CR25","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","volume":"15","author":"DE Johnson","year":"2018","unstructured":"Johnson DE, O\u2019Keefe RA, Grandis JR. Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer. Nat Rev Clin Oncol. 2018;15:234\u201348. https:\/\/doi.org\/10.1038\/nrclinonc.2018.8.","journal-title":"Nat Rev Clin Oncol"},{"key":"2014_CR26","doi-asserted-by":"publisher","first-page":"721030","DOI":"10.3389\/fimmu.2021.721030","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang X, Wang Y, Qu GAC, Chen J. Pan-Cancer analysis of PARP1 alterations as biomarkers in the prediction of immunotherapeutic effects and the association of its expression levels and immunotherapy signatures. Front Immunol. 2021;12:721030. https:\/\/doi.org\/10.3389\/fimmu.2021.721030.","journal-title":"Front Immunol"},{"key":"2014_CR27","doi-asserted-by":"publisher","first-page":"e0243509","DOI":"10.1371\/journal.pone.0243509","volume":"15","author":"J Jin","year":"2020","unstructured":"Jin J, Robeson H, Fagan P, Orloff MS. Association of PARP1-specific polymorphisms and haplotypes with non-small cell lung cancer subtypes. PLoS ONE. 2020;15:e0243509. https:\/\/doi.org\/10.1371\/journal.pone.0243509.","journal-title":"PLoS ONE"},{"key":"2014_CR28","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1158\/2159-8290.CD-16-1250","volume":"7","author":"J de Bono","year":"2017","unstructured":"de Bono J, Ramanathan RK, Mina L, Chugh R, Glaspy J, Rafii S, Kaye S, Sachdev J, Heymach J, Smith DC, Henshaw JW, Herriott A, Patterson M, Curtin NJ, Byers LA, Wainberg ZA, Phase I. Dose-Escalation, Two-Part trial of the PARP inhibitor Talazoparib in patients with advanced germline BRCA1\/2 mutations and selected sporadic cancers. Cancer Discov. 2017;7:620\u20139. https:\/\/doi.org\/10.1158\/2159-8290.CD-16-1250.","journal-title":"Cancer Discov"},{"key":"2014_CR29","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/ajh.23244","volume":"87","author":"X Bi","year":"2012","unstructured":"Bi X, Zheng T, Lan Q, Xu Z, Chen Y, Zhu G, Foss F, Kim C, Dai M, Zhao P, Holford T, Leaderer B, Boyle P, Deng Q, Chanock SJ, Rothman N, Zhang Y. Genetic polymorphisms in IL10RA and TNF modify the association between blood transfusion and risk of non-Hodgkin lymphoma. Am J Hematol. 2012;87:766\u20139. https:\/\/doi.org\/10.1002\/ajh.23244.","journal-title":"Am J Hematol"},{"key":"2014_CR30","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1002\/jmv.24501","volume":"88","author":"DC Aroucha","year":"2016","unstructured":"Aroucha DC, Carmo RF, Vasconcelos LRS, Lima RE, Mendon\u00e7a TF, Arnez LE, do M, Cavalcanti SM, Muniz MTC, Aroucha ML, Siqueira ER, Pereira LB, Moura P, Pereira LMMB, Co\u00ealho MR. TNF-\u03b1 and IL-10 polymorphisms increase the risk to hepatocellular carcinoma in HCV infected individuals. J Med Virol. 2016;88:1587\u201395. https:\/\/doi.org\/10.1002\/jmv.24501.","journal-title":"J Med Virol"},{"key":"2014_CR31","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/cei.13446","volume":"201","author":"Q Liu","year":"2020","unstructured":"Liu Q, Hua M, Yan S, Zhang C, Wang R, Yang X, Han F, Hou M, Ma D. Immunorelated gene polymorphisms associated with acute myeloid leukemia. Clin Exp Immunol. 2020;201:266\u201378. https:\/\/doi.org\/10.1111\/cei.13446.","journal-title":"Clin Exp Immunol"},{"key":"2014_CR32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3109\/08916934.2011.622013","volume":"45","author":"M Morita","year":"2012","unstructured":"Morita M, Watanabe M, Inoue N, Inaoka C, Akamizu T, Tatsumi K-I, Hidaka Y, Iwatani Y. Functional polymorphisms in TBX21 and HLX are associated with development and prognosis of graves\u2019 disease. Autoimmunity. 2012;45:129\u201336. https:\/\/doi.org\/10.3109\/08916934.2011.622013.","journal-title":"Autoimmunity"},{"key":"2014_CR33","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00277-018-3227-7","volume":"97","author":"L Zhao","year":"2018","unstructured":"Zhao L, Zhu H, Han B, Wang L, Sun Y, Lu X, Huang C, Tan B, Chen C, Qin L. Influence of genetic polymorphisms of IL23R, STAT3, IL12B, and STAT4 on the risk of aplastic anemia and the effect of immunosuppressive therapy. Ann Hematol. 2018;97:685\u201395. https:\/\/doi.org\/10.1007\/s00277-018-3227-7.","journal-title":"Ann Hematol"},{"key":"2014_CR34","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1093\/annonc\/mdu451","volume":"25","author":"Q Zhang","year":"2014","unstructured":"Zhang Q, Ji XW, Hou XM, Lu FM, Du Y, Yin JH, Sun XY, Deng Y, Zhao J, Han X, Yang GS, Zhang HW, Chen XM, Shen HB, Wang HY, Cao GW. Effect of functional nuclear factor-kappaB genetic polymorphisms on hepatitis B virus persistence and their interactions with viral mutations on the risk of hepatocellular carcinoma. Ann Oncol Off J Eur Soc Med Oncol. 2014;25:2413\u20139. https:\/\/doi.org\/10.1093\/annonc\/mdu451.","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"2014_CR35","doi-asserted-by":"publisher","first-page":"e0248259","DOI":"10.1371\/journal.pone.0248259","volume":"16","author":"RD Gaiolla","year":"2021","unstructured":"Gaiolla RD, de Moraes MP, de Oliveira DE. SNPs in genes encoding for IL-10, TNF-\u03b1, and NF\u03baB p105\/p50 are associated with clinical prognostic factors for patients with hodgkin lymphoma. PLoS ONE. 2021;16:e0248259. https:\/\/doi.org\/10.1371\/journal.pone.0248259.","journal-title":"PLoS ONE"},{"key":"2014_CR36","doi-asserted-by":"publisher","first-page":"e146950","DOI":"10.1172\/JCI146950","volume":"131","author":"WJ Ho","year":"2021","unstructured":"Ho WJ, Croessmann S, Lin J, Phyo ZH, Charmsaz S, Danilova L, Mohan AA, Gross NE, Chen F, Dong J, Aggarwal D, Bai Y, Wang J, He J, Leatherman JM, Yarchoan M, Armstrong TD, Zaidi N, Fertig EJ, Denny JC, Park BH, Zhang Z-Y, Jaffee EM. Systemic Inhibition of PTPN22 augments anticancer immunity. J Clin Invest. 2021;131:e146950. https:\/\/doi.org\/10.1172\/JCI146950.","journal-title":"J Clin Invest"},{"key":"2014_CR37","doi-asserted-by":"publisher","unstructured":"Zhou L, Wang K, Wang J, Zhou Z, Cheng Y, Pan X, Ma A. PTPN22 Gene Polymorphisms Are Associated with Susceptibility to Large Artery Atherosclerotic Stroke and Microembolic Signals, Dis. Markers 2019 (2019) 2193835. https:\/\/doi.org\/10.1155\/2019\/2193835","DOI":"10.1155\/2019\/2193835"},{"key":"2014_CR38","doi-asserted-by":"publisher","first-page":"40","DOI":"10.14336\/AD.2017.0308","volume":"9","author":"J Liu","year":"2018","unstructured":"Liu J, Tang L-Y, Wang Y-G, Lu S-Y, Zhang E-N, Wang Z-G, Zhang H-X. Identification of MAVS as a novel risk factor for the development of osteoarthritis. Aging Dis. 2018;9:40\u201350. https:\/\/doi.org\/10.14336\/AD.2017.0308.","journal-title":"Aging Dis"},{"key":"2014_CR39","doi-asserted-by":"publisher","unstructured":"Zhang W, Gong J, Yang H, Wan L, Peng Y, Wang X, Sun J, Li F, Geng Y, Li D, Liu N, Mei G, Cao Y, Yan Q, Li H, Zhang Y, He X, Zhang Q, Zhang R, Wu F, Zhong H, Wei C. The mitochondrial protein MAVS stabilizes p53 to suppress tumorigenesis, cell rep. 30 (2020) 725\u2013e7384. https:\/\/doi.org\/10.1016\/j.celrep.2019.12.051","DOI":"10.1016\/j.celrep.2019.12.051"},{"key":"2014_CR40","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S1470-2045(18)30932-X","volume":"20","author":"J-H Wei","year":"2019","unstructured":"Wei J-H, Feng Z-H, Cao Y, Zhao H-W, Chen Z-H, Liao B, Wang Q, Han H, Zhang J, Xu Y-Z, Li B, Wu J-T, Qu G-M, Wang G-P, Liu C, Xue W, Liu Q, Lu J, Li C-X, Li P-X, Zhang Z-L, Yao H-H, Pan Y-H, Chen W-F, Xie D, Shi L, Gao Z-L, Huang Y-R, Zhou F-J, Wang S-G, Liu Z-P, Chen W, Luo J-H. Predictive value of single-nucleotide polymorphism signature for recurrence in localised renal cell carcinoma: a retrospective analysis and multicentre validation study. Lancet Oncol. 2019;20:591\u2013600. https:\/\/doi.org\/10.1016\/S1470-2045(18)30932-X.","journal-title":"Lancet Oncol"},{"key":"2014_CR41","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1182\/blood-2017-11-814608","volume":"131","author":"G Kleinstern","year":"2018","unstructured":"Kleinstern G, Camp NJ, Goldin LR, Vachon CM, Vajdic CM, de Sanjose S, Weinberg JB, Benavente Y, Casabonne D, Liebow M, Nieters A, Hjalgrim H, Melbye M, Glimelius B, Adami H-O, Boffetta P, Brennan P, Maynadie M, McKay J, Cocco PL, Shanafelt TD, Call TG, Norman AD, Hanson C, Robinson D, Chaffee KG, Brooks-Wilson AR, Monnereau A, Clavel J, Glenn M, Curtin K, Conde L, Bracci PM, Morton LM, Cozen W, Severson RK, Chanock SJ, Spinelli JJ, Johnston JB, Rothman N, Skibola CF, Leis JF, Kay NE, Smedby KE, Berndt SI, Cerhan JR, Caporaso N, Slager SL. Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis. Blood. 2018;131:2541\u201351. https:\/\/doi.org\/10.1182\/blood-2017-11-814608.","journal-title":"Blood"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02014-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-025-02014-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02014-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T16:54:34Z","timestamp":1767200074000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-025-02014-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2014"],"URL":"https:\/\/doi.org\/10.1007\/s00011-025-02014-7","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"8 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"The institutional ethics committee of the Qilu Hospital of Shandong University approved the study (approval code: KYLL-202204-059). In accordance with the Declaration of Helsinki, informed consent was obtained from all patients and controls.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"73"}}